Related Experiment Video

Updated: Aug 17, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

Modeling resistance to pathway-targeted therapy in ovarian cancer

Deyin Xing1, Sandra Orsulic

  • 1Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. dxing@partners.org

Cell Cycle (Georgetown, Tex.)
|June 23, 2005
PubMed

Insights

Understanding how biochemical pathways cooperate is key for effective cancer therapy. This study uses engineered mouse models to explore pathway interactions and resistance to targeted treatments.

Area of Science:

  • Biochemistry
  • Oncology
  • Molecular Biology

Background:

  • Targeted cancer therapies require understanding biochemical pathways in cancer initiation and progression.
  • Cancer development involves complex cooperation and cross-talk between multiple biochemical pathways.
  • Redundant pathways contribute to therapeutic resistance, limiting the efficacy of single-target agents.

Purpose of the Study:

  • To simulate and investigate the cooperation of multiple biochemical pathways in cancer development.
  • To determine the functional roles of individual pathways in cell proliferation and tumor maintenance.
  • To analyze the molecular mechanisms underlying tumor resistance to pathway-targeted therapies.

Main Methods:

  • Engineering mouse ovarian cancer cell lines and tumors with defined genetic alterations.
  • Utilizing these engineered models to study biochemical pathway interactions.
  • Testing the efficacy and resistance mechanisms of pathway-targeted therapies in vivo.

Main Results:

  • Demonstrated the functional contributions of specific biochemical pathways to cancer cell proliferation.
  • Identified key pathways essential for tumor maintenance in engineered models.
  • Provided insights into the molecular mechanisms driving tumor resistance to targeted therapies.

Conclusions:

  • Cooperation between biochemical pathways is a critical factor in cancer development and progression.
  • Engineered mouse models are valuable tools for dissecting pathway interactions and therapeutic resistance.
  • Findings contribute to the design of more effective, multi-targeted cancer therapies.

More Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...